SCHEMBL4466672

SCHEMBL4466672

O=C(C(=NO)c1ccnc(Cl)c1)c1ccc(F)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
LTA4H P09960 1/20 0.39
KCNQ3 O43525 1/20 0.38
KCNQ2 O43526 1/20 0.38
KCNE1 P15382 1/20 0.38
KCNQ1 P51787 1/20 0.38
BACE1 P56817 1/20 0.38
KMT2A Q03164 1/20 0.36
TAS1R3 Q7RTX0 2/20 0.35
TAS1R1 Q7RTX1 2/20 0.35
TAS1R2 Q8TE23 2/20 0.35
GRM5 P41594 2/20 0.35
KDM5A P29375 2/20 0.34
KDM4C Q9H3R0 2/20 0.34
KDM5B Q9UGL1 2/20 0.34
KDM4A O75164 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
KDM2B Q8NHM5 1/20 0.33
SMARCA2 P51531 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4466668 1.00 CES2 (0.42) CES2CES1LTA4HKCNQ3KCNQ2
SCHEMBL828659 0.85 CES2 (0.44) CES2CES1LTA4HKMT2ATAS1R3
SCHEMBL830162 0.85 CES2 (0.44) CES2CES1LTA4HKMT2ATAS1R3
SCHEMBL828398 0.85 CES2 (0.44) CES2CES1LTA4HKMT2ATAS1R3
SCHEMBL10080304 0.85 CES1 (0.55) CES2CES1LTA4HKCNQ3KCNQ2
SCHEMBL4459279 0.83 CES2 (0.42) CES2CES1LTA4HKMT2AGRM5
SCHEMBL4459277 0.83 CES2 (0.42) CES2CES1LTA4HKMT2AGRM5
SCHEMBL2847108 0.79 LTA4H (0.41) CES2CES1LTA4HKMT2ATAS1R3
SCHEMBL2847107 0.79 LTA4H (0.41) CES2CES1LTA4HKMT2ATAS1R3
SCHEMBL1150732 0.79 LTA4H (0.59) CES2CES1LTA4HKMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582660-B2 2-thio-substituted imidazole derivatives and their use in pharmaceutics C-A-I-R BIOSCIENCES GMBH (DE) 2009-09-01 US disclosed
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics MERCKLE-GMBH (DE) 2006-10-19 US disclosed
EP-1539741-A1 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS MERCKLE GMBH (DE) 2005-06-15 EP disclosed
WO-2004018458-A1 2-THIO-SUBSTITUTED IMIDAZOLE DERIVATIVES AND THEIR USE IN PHARMACEUTICS MERCKLE-GMBH (DE) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235054-A1 2-Thio-substituted imidazole derivatives and their use in pharmaceutics IL2, TPMT, IFNG CES2 1940/4885CES1 964/4885LTA4H 703/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.